Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma

Human Pathology

Volumn 42, Issue 3, 2011, Pages 315-323

  Kim, Jin Man ^a   Kang, Dong Wook ^b   Long, Liang Zhe ^a   Huang, Song Mei ^a   Yeo, Min Kyung ^a   Yi, Eunhee S ^c   Kim, Kyung Hee ^a  

^a Chungnam National University   (South Korea)

^b Eulji University   (South Korea)

^c MAYO CLINIC   (United States)

Author keywords

Adenocarcinoma; Cell cycle; EGFR; Lung; Squamous cell carcinoma; Yes associated protein

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CELL NUCLEUS; FEMALE; GENE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; YAP GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYCLINS; DIAGNOSTIC IMAGING; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-YES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE ARRAY ANALYSIS;

EID: 79951581362     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.08.003     Document Type: Article

References (23)

1. Jemal A., Siegel R., and Ward E. Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66 (Pubitemid 46148091)
2. Wang Y., Dong Q., and Zhang Q. Overexpression of Yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer Cancer Sci 101 2010 1279 1285
3. Steinhardt A.A., Gayyed M.F., and Klein A.P. Expression of Yes-associated protein in common solid tumors Hum Pathol 39 2008 1582 1589
4. Dong J., Feldmann G., and Huang J. Elucidation of a universal size-control mechanism in Drosophila and mammals Cell 130 2007 1120 1133 (Pubitemid 47410268)
5. Edgar B.A. From cell structure to transcription: Hippo forges a new path Cell 124 2006 267 273 (Pubitemid 43121976)
6. Xu M.Z., Yao T.J., and Lee N.P. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma Cancer 115 2009 4576 4585
7. Roberts P.J., and Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 2007 3291 3310 (Pubitemid 46763022)
8. Sharma S.V., Bell D.W., Settleman J., and Haber D.A. Epidermal growth factor receptor mutations in lung cancer Nat Rev Cancer 7 2007 169 181
9. Hirsch F.R., Varella-Garcia M., and Bunn P.A. Jr Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 2003 3798 3807 (Pubitemid 46606235)
10. G. Sica, A. Yoshizawa, and C.S. Sima A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors Am J Surg Pathol 34 2010 1155 1162
11. Greene F.L.P.D., Fleming I.D., and A.G. Fritz AJCC cancer staging manual 6th ed. 2002 Springer-Verlag New York, NY
12. Allred D.C., Harvey J.M., Berardo M., and Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 1998 155 168 (Pubitemid 28144151)
13. Hirsch F.R., Varella-Garcia M., and McCoy J. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group study J Clin Oncol 23 2005 6838 6845
14. Cappuzzo F., Hirsch F.R., and Rossi E. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 2005 643 655 (Pubitemid 40812628)
15. Zender L., Spector M.S., and Xue W. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267 (Pubitemid 43929093)
16. Overholtzer M., Zhang J., and Smolen G.A. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Proc Natl Acad Sci U S A 103 2006 12405 12410 (Pubitemid 44267272)
17. Modena P., Lualdi E., and Facchinetti F. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics J Clin Oncol 24 2006 5223 5233 (Pubitemid 46631366)
18. Yuan M., Tomlinson V., and Lara R. Yes-associated protein (YAP) functions as a tumor suppressor in breast Cell Death Differ 15 2008 1752 1759
19. Basu S., Totty N.F., Irwin M.S., Sudol M., and Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis Mol Cell 11 2003 11 23 (Pubitemid 36126587)
20. Kanai F., Marignani P.A., and Sarbassova D. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins EMBO J 19 2000 6778 6791 (Pubitemid 32011671)
21. Komuro A., Nagai M., Navin N.E., and Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus J Biol Chem 278 2003 33334 33341 (Pubitemid 37055785)
22. Wang K., Degerny C., Xu M., and Yang X.J. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease Biochem Cell Biol 87 2009 77 91
23. Gaiser T., Waha A., and Moessler F. Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas Mod Pathol 22 2009 1263 1271